May 2 |
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
|
May 2 |
Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
|
Apr 29 |
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler
|
Apr 20 |
Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher
|
Apr 15 |
Certain Biotech Investors Get an Early Look at Results. Is That Fair?
|
Apr 10 |
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
|
Apr 9 |
Taysha draws bullish view at Piper Sandler on lead asset
|
Apr 9 |
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Mar 24 |
News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts
|
Mar 21 |
Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations
|